The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Processes For The Production Of Oligonucleotides - EP3481838

The patent EP3481838 was granted to Glaxosmithkline on Aug 19, 2020. The application was filed on Jul 7, 2017 under application number EP17739936A. The patent is currently recorded with a legal status of "Revoked".

EP3481838

GLAXOSMITHKLINE
Application Number
EP17739936A
Filing Date
Jul 7, 2017
Status
Revoked
Jul 1, 2025
Publication Date
Aug 19, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JANSSEN PHARMACEUTICAMay 19, 2021KILBURN & STRODEADMISSIBLE
JG OPPOSITIONSMay 19, 2021FORDADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS6004826
INTERNATIONAL-SEARCH-REPORTWO0164864
INTERNATIONAL-SEARCH-REPORTWO0171037
INTERNATIONAL-SEARCH-REPORTWO2009097673
OPPOSITIONUS2003008306
OPPOSITIONUS2003228602
OPPOSITIONUS5547843
OPPOSITIONUS5998175
OPPOSITIONUS6004826
OPPOSITIONUS8148065
OPPOSITIONWO0127326
OPPOSITIONWO0129211
OPPOSITIONWO0164864
OPPOSITIONWO0171037
OPPOSITIONWO2004029223
OPPOSITIONWO2009097673

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents